Back to Report Store Home

Frontier Pharma: Dermatology – Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation

  • Published: Jun-2017
  • Report Code: GBIHC444MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Dermatology Therapeutics Market, US, Innovation Trends in Product Approvals, Number of Product Approvals by FDA and Five-Year Moving Average of Product Approvals, 1987–2014 8

Figure 2: Dermatology Therapeutics Market, Sales Performance of First-in-Class and Non-First-in-Class Products Post Marketing Approval ($m), 2006–2013 9

Figure 3: Dermatology Therapeutics Market, Global, Marketed Products by Molecule Type, 2017 20

Figure 4: Dermatology Therapeutics Market, Global, Marketed Products by Molecular Target, 2017 21

Figure 5: Dermatology Therapeutics Market, Global, Overall Pharmaceutical Industry Pipeline by Therapy Area, 2017 22

Figure 6: Dermatology Therapeutics Market, Global, Pipeline by Stage of Development and Molecule Type, 2017 23

Figure 7: Dermatology Therapeutics Market, Global, Pipeline by Molecular Target and Stage of Development, 2017 25

Figure 8: Dermatology Therapeutics Market, Global, Distribution of Pipeline First-in-Class and Non-First-in-Class Products by Stage of Development and Molecular Target, 2017 26

Figure 9: Dermatology Therapeutics Market, Global, Percentage Distribution of First-in-Class and Non-First-in-Class Pipeline Products by Stage of Development (%), 2017 27

Figure 10: Dermatology Therapeutics Market, Global, Percentage Distribution of First-in-Class and Non-First-in-Class Pipeline Products by Molecular Target (%), 2017 27

Figure 11: Dermatology Therapeutics Market, Global, Ratio of First-in-Class Products to First-in-Class Targets by Stage of Development, 2017 27

Figure 12: Dermatology Therapeutics Market, Global, Ratio of First-in-Class Products to First-in-Class Targets by Molecular Target, 2017 28

Figure 13: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 1) 28

Figure 14: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 2) 29

Figure 15: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 3) 30

Figure 16: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 4) 31

Figure 17: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 5) 32

Figure 18: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 6) 33

Figure 19: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 7) 33

Figure 20: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 8) 34

Figure 21: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 9) 35

Figure 22: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 10) 36

Figure 23: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 11) 37

Figure 24: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 12) 38

Figure 25: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 13) 39

Figure 26: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 14) 40

Figure 27: Dermatology Therapeutics Market, Global, Pipeline Products, 2017 (Part 15) 41

Figure 28: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 1) 43

Figure 29: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 2) 44

Figure 30: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 3) 44

Figure 31: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 4) 45

Figure 32: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Inflammatory Diseases), 2017 (Part 5) 45

Figure 33: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Infectious Diseases), 2017 46

Figure 34: Dermatology Therapeutics Market, Global, First-in-Class Matrix Assessment (Wounds/Scars), 2017 47

Figure 35: Dermatology Therapeutics Market, Global, Industry-Wide Deals by Stage of Development and First-in-Class Status, 2006–2014 74

Figure 36: Dermatology Therapeutics Market, Global, Industry-Wide Licensing Deals by Deal Value, Upfront Payment Value, Stage of Development and First-in-Class Status, 2006–2014 75

Figure 37: Dermatology Therapeutics Market, Global, Licensing Deals by Region, Value and Year, 2006–2017 76

Figure 38: Dermatology Therapeutics Market, Global, Licensing Deals by Deal Value, Upfront Payment Value and Stage of Development, 2006–2017 77

Figure 39: Dermatology Therapeutics Market, Global, Number and Aggregate Deal Value of Licensing Deals by Molecule Type, 2006–2017 77

Figure 40: Dermatology Therapeutics Market, Global, Number and Aggregate Deal Value of Licensing Deals by Molecular Target, 2006–2017 78

Figure 41: Dermatology Therapeutics, Global, Licensing Deals with Disclosed Deal Values, 2006–2017 (Part 1) 79

Figure 42: Dermatology Therapeutics, Global, Licensing Deals with Disclosed Deal Values, 2006–2017 (Part 2) 80

Figure 43: Dermatology Therapeutics Market, Global, Co-development Deals by Region, Value and Year, 2006–2017 81

Figure 44: Dermatology Therapeutics Market, Global, Co-development Deals by Stage of Development, Deal Value and Upfront Payment Value, 2006–2017 82

Figure 45: Dermatology Therapeutics Market, Global, Number and Aggregate Deal Value of Co-development Deals by Molecule Type, 2006–2017 82

Figure 46: Dermatology Therapeutics Market, Global, Number of Co-development Deals by Molecular Target, 2006–2017 83

Figure 47: Dermatology Therapeutics Market, Global, Co-development Deals with Disclosed Deal Values, 2006–2017 84

Figure 48: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with Prior Involvement in Licensing or Co-development Deals, 2017 85

Figure 49: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 1), 2017 86

Figure 50: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 2), 2017 87

Figure 51: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 3), 2017 88

Figure 52: Dermatology Therapeutics Market, Global, First-in-Class Pipeline Products with No Disclosed Prior Involvement in Licensing or Co-development Deals (Part 4), 2017 89

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$6995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$13990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$20985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards